Moderna Coronavirus Vaccine Ready For Human Testing, Stocks Spike 22%

Moderna surged as much as 22% after the biotech company shipped the first coronavirus vaccine for human testing.

EXCLUSIVE: Coronavirus Bioweapon – How China Stole Coronavirus From Canada And Weaponized It (watch here Visualizing The Secret History Of Coronavirus)
Watch the exclusive interview of Bioweapons Expert Dr. Francis Boyle on Coronavirus Biological Warfare blocked by the Deep State

Moderna Coronavirus Vaccine Ready For Human Testing, Stocks Spike 22%

The firm submitted vials of mRNA-1273 to the National Institute of Allergy and Infectious Diseases for a phase one study in the US, according to a press release. Moderna is the first company to push a preventative vaccine for the outbreak to trial.

The company was able to deliver the first batch just 42 days after identifying the key RNA sequence to target, Juan Andres, chief technical operations and quality officer, said. Andres attri...

Limited Time

Full Access

$10
Monthly

Included:

  • Access to All Articles.
  • One Plan. No Tiers.
  • No Ads.
  • Cancel anytime.
register now

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].